Figure 6.
Visualization and quantification of rRNA inhibition through 5-EU (5-EU: heat map; DAPI: gray). Treatment conditions were 5 nM for ActD, 10 μM for oxaliplatin and cisplatin, and 0.5 μM for phenanthriplatin and 1–3 in A549 cells at 24 h treatment (n = 3). Scale bar = 10 μm, ***p < 0.05, N.S. p > 0.05.
